Skip to main content
Erschienen in: Clinical Oral Investigations 2/2016

01.03.2016 | Original Article

Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft

verfasst von: Thomas Hoffmann, Elyan Al-Machot, Jörg Meyle, Pia-Merete Jervøe-Storm, Søren Jepsen

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aims to compare the clinical outcomes of a combination of enamel matrix derivatives (EMD) and a synthetic bone graft (biphasic calcium phosphate) with EMD alone in wide and deep one- and two-wall intrabony defects 36 months after treatment.

Material and methods

Thirty patients with chronic periodontitis and one wide (≥ 2 mm) and deep (≥ 4 mm) intrabony defect had been recruited in three centres in Germany. During surgery, defects were randomly assigned to EMD/synthetic bone graft (SBG) (test) or EMD (control). Assessments at baseline, after 6, 12 and 36 months, included bone sounding, relative clinical attachment levels, probing pocket depths and recessions.

Results

After 36 months, defects in both groups were significantly improved (p < 0.001) with regard to defect fill, attachment gain and probing pocket reduction. In the EMD/SBG group, a mean defect fill of 2.6 mm (±1.7) was measured, and in the EMD group, the defect fill was 2.3 mm (±1.5). A mean gain in clinical attachment of 4.1 mm (±3.6) and 3.8 mm (±2.2) was observed in the test and in the control group, respectively. There were no statistically significant differences in any of the investigated parameters between the two treatment modalities.

Conclusions

The clinical improvements of advanced intrabony defects obtained with both regenerative modalities could be maintained over a period of 3 years. The combination of EMD with SBG did not show any advantage compared to the use of EMD alone.
Literatur
1.
Zurück zum Zitat Hammarström L, Heijl L, Gestrelius S (1997) Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24:669–677CrossRefPubMed Hammarström L, Heijl L, Gestrelius S (1997) Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24:669–677CrossRefPubMed
2.
Zurück zum Zitat Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys. J Clin Periodontol 27:466–472CrossRefPubMed Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys. J Clin Periodontol 27:466–472CrossRefPubMed
3.
Zurück zum Zitat Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696CrossRefPubMed Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696CrossRefPubMed
4.
Zurück zum Zitat Mellonig J (1999) Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restorative Dent 19:9–19 Mellonig J (1999) Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restorative Dent 19:9–19
5.
Zurück zum Zitat Sculean A, Donos N, Windisch P, Brecx M, Gera I, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322CrossRefPubMed Sculean A, Donos N, Windisch P, Brecx M, Gera I, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322CrossRefPubMed
6.
Zurück zum Zitat Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restorative Dent 20:374–381PubMed Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restorative Dent 20:374–381PubMed
7.
Zurück zum Zitat Heijl L, Heden G, Svardström G, Ostgren A (1997) Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714CrossRefPubMed Heijl L, Heden G, Svardström G, Ostgren A (1997) Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714CrossRefPubMed
8.
Zurück zum Zitat Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 72:25–34CrossRefPubMed Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 72:25–34CrossRefPubMed
9.
Zurück zum Zitat Tonetti MS, Fourmousis I, Suvan J, Cortellini P, Bragger U, Lang NP (2004) Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol 31:1092–1098CrossRefPubMed Tonetti MS, Fourmousis I, Suvan J, Cortellini P, Bragger U, Lang NP (2004) Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol 31:1092–1098CrossRefPubMed
10.
Zurück zum Zitat Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol 29:317–325CrossRefPubMed Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol 29:317–325CrossRefPubMed
11.
Zurück zum Zitat Venezia E, Goldstein M, Boyan BD, Schwartz Z (2004) The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis. Crit Rev Oral Biol Med 15:382–402CrossRefPubMed Venezia E, Goldstein M, Boyan BD, Schwartz Z (2004) The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis. Crit Rev Oral Biol Med 15:382–402CrossRefPubMed
12.
Zurück zum Zitat Pietruska MD (2001) A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 109:178–181CrossRefPubMed Pietruska MD (2001) A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 109:178–181CrossRefPubMed
13.
Zurück zum Zitat Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403CrossRefPubMed Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403CrossRefPubMed
14.
Zurück zum Zitat Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M (2002) Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol 73:401–408CrossRefPubMed Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M (2002) Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol 73:401–408CrossRefPubMed
15.
Zurück zum Zitat Sculean A, Chiantella GC, Windisch P, Gera I, Reich E (2002) Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 22:259–267PubMed Sculean A, Chiantella GC, Windisch P, Gera I, Reich E (2002) Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 22:259–267PubMed
16.
Zurück zum Zitat Rosen PS, Reynolds MA (2002) A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Periodontol 73:942–949CrossRefPubMed Rosen PS, Reynolds MA (2002) A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Periodontol 73:942–949CrossRefPubMed
17.
Zurück zum Zitat Döri F, Arweiler N, Gera I, Sculean A (2005) Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. J Periodontol 76:2236–2243CrossRefPubMed Döri F, Arweiler N, Gera I, Sculean A (2005) Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. J Periodontol 76:2236–2243CrossRefPubMed
18.
Zurück zum Zitat Trombelli L, Farina R (2008) Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol 35:117–135CrossRefPubMed Trombelli L, Farina R (2008) Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol 35:117–135CrossRefPubMed
19.
Zurück zum Zitat Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71:1110–1116CrossRefPubMed Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71:1110–1116CrossRefPubMed
20.
Zurück zum Zitat Velasquez-Plata D, Scheyer ET, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 73:433–440CrossRefPubMed Velasquez-Plata D, Scheyer ET, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 73:433–440CrossRefPubMed
21.
Zurück zum Zitat Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735CrossRefPubMed Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735CrossRefPubMed
22.
Zurück zum Zitat Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L (2007) Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78:231–238CrossRefPubMed Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L (2007) Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78:231–238CrossRefPubMed
23.
Zurück zum Zitat Yilmaz S, Cakar G, Yildirim B, Sculean A (2010) Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J Clin Periodontol 37:544–550CrossRefPubMed Yilmaz S, Cakar G, Yildirim B, Sculean A (2010) Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J Clin Periodontol 37:544–550CrossRefPubMed
24.
Zurück zum Zitat Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. J Periodontol 63:729–735CrossRefPubMed Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. J Periodontol 63:729–735CrossRefPubMed
25.
Zurück zum Zitat Piattelli A, Scarano A, Mangano C (1996) Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials 17:1767–1770CrossRefPubMed Piattelli A, Scarano A, Mangano C (1996) Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials 17:1767–1770CrossRefPubMed
26.
Zurück zum Zitat Daculsi G, Weiss P, Bouler JM, Gauthier O, Millot F, Aguado E (1999) Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials. Bone 25:59S–61SCrossRefPubMed Daculsi G, Weiss P, Bouler JM, Gauthier O, Millot F, Aguado E (1999) Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials. Bone 25:59S–61SCrossRefPubMed
27.
Zurück zum Zitat Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D (2007) Evaluation of a novel biphasic calcium phosphate in standardized bone defects. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Impants Res 18:752–760CrossRef Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D (2007) Evaluation of a novel biphasic calcium phosphate in standardized bone defects. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Impants Res 18:752–760CrossRef
28.
Zurück zum Zitat Stein JM, Fickl S, Yekta SS, Hoischen U, Ocklenburg C, Smeets R (2009) Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. J Periodontol 80:1774–1782CrossRefPubMed Stein JM, Fickl S, Yekta SS, Hoischen U, Ocklenburg C, Smeets R (2009) Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. J Periodontol 80:1774–1782CrossRefPubMed
29.
Zurück zum Zitat Jepsen S, Topoll H, Rengers H, Heinz B, Teich M, Hoffmann T, Al-Machot E, Meyle J, Jervøe-Storm PM (2008) Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial. J Clin Periodontol 35:420–428CrossRefPubMed Jepsen S, Topoll H, Rengers H, Heinz B, Teich M, Hoffmann T, Al-Machot E, Meyle J, Jervøe-Storm PM (2008) Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial. J Clin Periodontol 35:420–428CrossRefPubMed
30.
Zurück zum Zitat Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm PM, Meiss C, Eickholz P, Jepsen S (2011) A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. J Clin Periodontol 38:652–660CrossRefPubMed Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm PM, Meiss C, Eickholz P, Jepsen S (2011) A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. J Clin Periodontol 38:652–660CrossRefPubMed
31.
Zurück zum Zitat Cortellini P, Prato GP, Tonetti MS (1995) The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 66:261–266CrossRefPubMed Cortellini P, Prato GP, Tonetti MS (1995) The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 66:261–266CrossRefPubMed
32.
Zurück zum Zitat Cortellini P, Prato GP, Tonetti MS (1999) The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 19:589–599PubMed Cortellini P, Prato GP, Tonetti MS (1999) The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 19:589–599PubMed
33.
Zurück zum Zitat Pontoriero R, Wennström JL, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840CrossRefPubMed Pontoriero R, Wennström JL, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840CrossRefPubMed
34.
Zurück zum Zitat Wachtel H, Schenk G, Bohm S, Weng D, Zuhr O, Hürzeler MB (2003) Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. J Clin Periodontol 30:496–504CrossRefPubMed Wachtel H, Schenk G, Bohm S, Weng D, Zuhr O, Hürzeler MB (2003) Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. J Clin Periodontol 30:496–504CrossRefPubMed
35.
Zurück zum Zitat Parodi R, Santarelli GA, Gasparetto B (2004) Treatment of intrabony pockets with Emdogain: results at 36 months. Int J Periodontics Restorative Dent 24:57–63PubMed Parodi R, Santarelli GA, Gasparetto B (2004) Treatment of intrabony pockets with Emdogain: results at 36 months. Int J Periodontics Restorative Dent 24:57–63PubMed
36.
Zurück zum Zitat Esposito M, Grusovin MG, Coulthard P, Worthington HV (2005) Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev CD003875 Esposito M, Grusovin MG, Coulthard P, Worthington HV (2005) Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev CD003875
37.
Zurück zum Zitat Francetti L, Trombelli L, Lombardo G, Guida L, Cafiero C, Roccuzzo M, Carusi G, Del Fabbro M (2005) Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study. Int J Periodontics Restorative Dent 25:461–473PubMed Francetti L, Trombelli L, Lombardo G, Guida L, Cafiero C, Roccuzzo M, Carusi G, Del Fabbro M (2005) Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study. Int J Periodontics Restorative Dent 25:461–473PubMed
38.
Zurück zum Zitat Heden G, Wennström JL (2006) Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 77:295–301CrossRefPubMed Heden G, Wennström JL (2006) Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 77:295–301CrossRefPubMed
39.
Zurück zum Zitat Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M (2008) Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 35:817–824CrossRefPubMed Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M (2008) Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 35:817–824CrossRefPubMed
40.
Zurück zum Zitat Harrel SK, Wilson TG Jr, Nunn ME (2010) Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results. J Periodontol 81:435–441CrossRefPubMed Harrel SK, Wilson TG Jr, Nunn ME (2010) Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results. J Periodontol 81:435–441CrossRefPubMed
41.
Zurück zum Zitat Machtei EE (1997) Outcome variables for the study of periodontal regeneration. Ann Periodontol 2:229–239CrossRefPubMed Machtei EE (1997) Outcome variables for the study of periodontal regeneration. Ann Periodontol 2:229–239CrossRefPubMed
42.
Zurück zum Zitat Gurinsky BS, Mills MP, Mellonig JT (2004) Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75:1309–1318CrossRefPubMed Gurinsky BS, Mills MP, Mellonig JT (2004) Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75:1309–1318CrossRefPubMed
43.
Zurück zum Zitat Tu YK, Woolston A, Faggion CM Jr (2010) Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials. J Clin Periodontol 37:59–79CrossRefPubMed Tu YK, Woolston A, Faggion CM Jr (2010) Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials. J Clin Periodontol 37:59–79CrossRefPubMed
44.
Zurück zum Zitat Bokan I, Bill JS, Schlagenhauf U (2006) Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. J Clin Periodontol 33:885–893CrossRefPubMed Bokan I, Bill JS, Schlagenhauf U (2006) Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. J Clin Periodontol 33:885–893CrossRefPubMed
45.
Zurück zum Zitat Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C (2007) Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 34:507–513CrossRefPubMed Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C (2007) Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 34:507–513CrossRefPubMed
46.
Zurück zum Zitat Pietruska M, Pieruski J, Nagy K, Brecx M, Arweiler N, Sculean A (2012) Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. Clin Oral Investig 16:1191–1197CrossRefPubMed Pietruska M, Pieruski J, Nagy K, Brecx M, Arweiler N, Sculean A (2012) Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. Clin Oral Investig 16:1191–1197CrossRefPubMed
47.
Zurück zum Zitat De Leonardis D, Paolantonio M (2013) Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects. J Periodontol 84:444–455CrossRefPubMed De Leonardis D, Paolantonio M (2013) Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects. J Periodontol 84:444–455CrossRefPubMed
48.
Zurück zum Zitat Renvert S, Badersten A, Nilvéus R, Egelberg J (1981) Healing after treatment of periodontal intraosseous defects. I. Comparative study of clinical methods. J Clin Periodontol 8:387–399CrossRefPubMed Renvert S, Badersten A, Nilvéus R, Egelberg J (1981) Healing after treatment of periodontal intraosseous defects. I. Comparative study of clinical methods. J Clin Periodontol 8:387–399CrossRefPubMed
49.
Zurück zum Zitat Sculean A, Windisch P, Szendroi-Kiss D, Horvath A, Rosta P, Becker J, Gera I, Schwarz F (2008) Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 79:1991–1999CrossRefPubMed Sculean A, Windisch P, Szendroi-Kiss D, Horvath A, Rosta P, Becker J, Gera I, Schwarz F (2008) Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 79:1991–1999CrossRefPubMed
50.
Zurück zum Zitat Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A (2008) Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int J Periodontics Restorative Dent 28:153–161PubMed Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A (2008) Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int J Periodontics Restorative Dent 28:153–161PubMed
51.
Zurück zum Zitat Silvestri M, Rasperini G, Milani S (2011) 120 infrabony defects treated with regenerative therapy: long-term results. J Periodontol 82:668–675CrossRefPubMed Silvestri M, Rasperini G, Milani S (2011) 120 infrabony defects treated with regenerative therapy: long-term results. J Periodontol 82:668–675CrossRefPubMed
Metadaten
Titel
Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft
verfasst von
Thomas Hoffmann
Elyan Al-Machot
Jörg Meyle
Pia-Merete Jervøe-Storm
Søren Jepsen
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 2/2016
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-015-1522-4

Weitere Artikel der Ausgabe 2/2016

Clinical Oral Investigations 2/2016 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.